Optogenetic therapy shows safe step forward in vision restoration
Five years after a landmark result in a single patient, new findings from the first treated cohort show that optogenetic vision restoration can work beyond an individual case.
An international team led by José-Alain Sahel (University of Pittsburgh School of Medicine, Chair of the IOB Scientific Advisory Board) and Botond Roska at IOB has reported new results from the first clinical cohort of blind patients with advanced retinitis pigmentosa treated with optogenetic therapy.
The therapy combines gene therapy with light stimulating goggles to make surviving retinal ganglion cells responsive to light. More